» Articles » PMID: 20155623

Molecular Mechanisms of Green Tea Polyphenols

Overview
Journal Nutr Cancer
Publisher Routledge
Date 2010 Feb 16
PMID 20155623
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Tea, next to water, is the most popular beverage in the world. It has been suggested that tea consumption has the cancer-preventive effects. Epidemiological studies have indicated decreased cancer occurrence in people who regularly drink green tea. Research has also discovered numerous mechanisms of action to explain the biological effects of tea. The most abundant and popular compound studied in tea research is (-)-epigallocatechin-3-gallate or (-)-EGCG, which is a powerful antioxidant and can inhibit a number of tumor cell proliferation and survival pathways. Tea polyphenols are known to inhibit metaloproteonases, various protein kinases, and proteins that regulate DNA replication and transformation. We also reported that ester bond-containing tea polyphenols, for example, (-)-EGCG, potently and specifically inhibited the tumor proteasomal activity. We further demonstrated that methylation on green tea polyphenols under physiological conditions decreased their proteasome-inhibitory activity, contributing to decreased cancer-preventive effects of tea consumption. Since (-)-EGCG is unstable under physiological conditions, we also developed the peracetate-protected or prodrug form of (-)-EGCG, Pro-EGCG (1), and showed that Pro-EGCG (1) increases the bioavailability, stability, and proteasome-inhibitory and anticancer activities of (-)-EGCG in human breast cancer cells and tumors, demonstrating its potential use for cancer prevention and treatment.

Citing Articles

Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy.

Deng P, Hu C, Xiong Z, Li Y, Jiang J, Yang H Cancer Manag Res. 2019; 11:2425-2439.

PMID: 30988640 PMC: 6441461. DOI: 10.2147/CMAR.S187750.


Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women.

van den Brandt P Eur J Epidemiol. 2018; 33(2):183-200.

PMID: 29380105 PMC: 5871637. DOI: 10.1007/s10654-018-0359-y.


Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression.

Ratovitski E Curr Genomics. 2017; 18(2):175-205.

PMID: 28367075 PMC: 5345332. DOI: 10.2174/1389202917666160803165229.


Therapeutic properties of green tea against environmental insults.

Chen L, Mo H, Zhao L, Gao W, Wang S, Cromie M J Nutr Biochem. 2016; 40:1-13.

PMID: 27723473 PMC: 5124528. DOI: 10.1016/j.jnutbio.2016.05.005.


Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration.

Liu X, Bi Y Med Sci Monit. 2016; 22:3529-3534.

PMID: 27694793 PMC: 5063426. DOI: 10.12659/msm.897594.


References
1.
Adams J . Development of the proteasome inhibitor PS-341. Oncologist. 2002; 7(1):9-16. DOI: 10.1634/theoncologist.7-1-9. View

2.
Kane R, Farrell A, Sridhara R, Pazdur R . United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin Cancer Res. 2006; 12(10):2955-60. DOI: 10.1158/1078-0432.CCR-06-0170. View

3.
Khan S, Katiyar S, Agarwal R, Mukhtar H . Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res. 1992; 52(14):4050-2. View

4.
Ahn H, Hadizadeh K, Seul C, Yun Y, Vetter H, Sachinidis A . Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell. 1999; 10(4):1093-104. PMC: 25235. DOI: 10.1091/mbc.10.4.1093. View

5.
Kazi A, Wang Z, Kumar N, Falsetti S, Chan T, Dou Q . Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors. Anticancer Res. 2004; 24(2B):943-54. View